• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.16% Nasdaq Down 0.13%

    Epizyme, Inc. (EPZM)

    -NasdaqGS
    18.79 Up 0.09(0.48%) Jun 2, 4:00PM EDT
    |After Hours : 18.79 0.00 (0.00%) Jun 2, 4:32PM EDT
    Add to Portfolio
    Prev Close:18.70
    Open:18.51
    Bid:16.75 x 200
    Ask:18.90 x 100
    1y Target Est:38.67
    Beta:3.513
    Earnings Date:Aug 11 - Aug 17 (Est.)
    Day's Range:18.29 - 19.32
    52wk Range:15.51 - 40.98
    Volume:137,146
    Avg Vol (3m):413,734
    Market Cap:774.24M
    P/E (ttm):N/A
    EPS (ttm):-3.22
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    EPZMUp 0.48%774.24M
    GSKUp 0.20%106.84B
    NVSDown 0.33%249.15B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):26.63
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-4.13
    Quarterly EPS Est (Jun-15) :-0.74
    Mean Recommendation*:1.9
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Epizyme, Inc., a clinical stage biopharmaceutical company, discovers and develops epigenetic therapies for cancer patients. Its proprietary product platform creates small molecule inhibitors of a 96-member class of enzymes known as histone methylt... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback